According to ESSA Pharma's latest financial reports the company has ยฃ0.10 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-09-30 | ยฃ0.12 B | -18.92% |
2022-09-30 | ยฃ0.14 B | 3.13% |
2021-09-30 | ยฃ0.14 B | 138.47% |
2020-09-30 | ยฃ60.88 M | 40.36% |
2019-09-30 | ยฃ43.37 M | 281.13% |
2018-09-30 | ยฃ11.38 M | 285.28% |
2017-09-30 | ยฃ2.95 M | -57.38% |
2016-09-30 | ยฃ6.93 M | 565.24% |
2015-09-30 | ยฃ1.04 M | -54.26% |
2014-09-30 | ยฃ2.27 M |